Advanced search
Publication Cover
Drug Metabolism Reviews Volume 51, 2019 - Issue 3
Submit an article Journal homepage
2,282
Views
56
CrossRef citations to date
0
Altmetric
Review Articles

Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects

Rafaela CostaDepartment of Public Health and Forensic Sciences, and Medical Education, Faculty of Medicine, University of Porto, Porto, Portugal; Correspondence[email protected]
View further author information
,
Nuno G. OliveiraResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal; View further author information
&
Ricardo Jorge Dinis-OliveiraDepartment of Public Health and Forensic Sciences, and Medical Education, Faculty of Medicine, University of Porto, Porto, Portugal; ;UCIBIO, REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal; ;IINFACTS – Institute of Research and Advanced Training in Health Sciences and Technologies, Department of Sciences, University Institute of Health Sciences (IUCS), CESPU, CRL, Gandra, PortugalCorrespondence[email protected] [email protected]
View further author information
Pages 293-313 | Received 15 Feb 2019, Accepted 15 May 2019, Published online: 14 Jun 2019

Citations (56)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

João Mauricio Castaldelli-Maia, Victoria Camargos de Oliveira, Flávia Mariana Irber, Israel K. Blaas, Bernard Angerville, Anderson Sousa Martins-da-Silva, Gislaine Koch Gimenes, Marcela Waisman Campos, Julio Torales, Antonio Ventriglio, Carine Guillois, Houria El Ouazzani, Léna Gazaix, Pascal Favré, Alain Dervaux & Gisèle Apter. (2023) Psychopharmacology of smoking cessation medications: focus on patients with mental health disorders. International Review of Psychiatry 35:5-6, pages 397-417.
Read now
Kristen Ward & Leslie Citrome. (2022) AXS-05: an investigational treatment for Alzheimer’s disease-associated agitation. Expert Opinion on Investigational Drugs 31:8, pages 773-780.
Read now
Michael C. Beuhler, Henry A. Spiller, Dalia Alwasiyah, Robert Bassett, Jeanette Trella, Martin Huecker & Ashley N. Webb. (2022) Adverse effects associated with bupropion therapeutic errors in adults reported to four United States Poison Centers. Clinical Toxicology 60:5, pages 623-627.
Read now
Tomoyuki Nagata, Shunichiro Shinagawa, Shinichiro Nakajima, Yoshihiro Noda & Masaru Mimura. (2022) Pharmacotherapeutic combinations for the treatment of Alzheimer’s disease. Expert Opinion on Pharmacotherapy 23:6, pages 727-737.
Read now
Alexander M. Sidlak, Karl O. Koivisto, Ryan T. Marino & Michael G. Abesamis. (2020) Serotonin toxicity from isolated bupropion overdoses. Clinical Toxicology 58:12, pages 1347-1349.
Read now
Nurgul Bozkurt & Ali Ihsan Bozkurt. Relationship between anxiety and depression with smoking cessation treatments: a follow-up study. Journal of Substance Use 0:0, pages 1-6.
Read now

Articles from other publishers (50)

Seetal Dodd, Jodie Harper & Michael Berk. (2024) Current Pharmacotherapies for Smoking Cessation and Promising Emerging Drugs. Current Reviews in Clinical and Experimental Pharmacology 19:3, pages 259-268.
Crossref
Rongrong Lu, Ying Jiang, Zhiqiang Du, Qin Zhou, Yuan Shen & Haohao Zhu. (2024) Multidimensional assessment of adverse events of bupropion: A large-scale data analysis from the FAERS database. Journal of Affective Disorders 354, pages 649-655.
Crossref
Evan D. Kharasch & Eric J. Lenze. (2024) Pharmacogenetic Influence on Stereoselective Steady-State Disposition of Bupropion. Drug Metabolism and Disposition 52:5, pages 455-466.
Crossref
Greg Noe, Kaushal ShahSamantha OngchuanSahil Munjal. (2024) Clinical Presentations of Bupropion Prescription Drug Misuse. Journal of Clinical Psychopharmacology 44:3, pages 284-290.
Crossref
Evelyn Mianes Besckow, Kauane Nayara Bahr Ledebuhr, Camila Simões Pires, Marcia Juciele da Rocha, Natália Emanuele Biolosor Kuntz, Benhur Godoi, Cristiani Folharini Bortolatto & César Augusto Brüning. (2024) Dopaminergic Modulation and Computational ADMET Insights for the Antidepressant-like Effect of N -(3-(Phenylselanyl)prop-2-yn-1-yl)benzamide . ACS Chemical Neuroscience 15:9, pages 1904-1914.
Crossref
Sehrish Zehra, Muhammad Asad Saeed, M. Zaman, Sadia Hassan & Fazal-Ur-Rehman. (2024) High-performance liquid chromatography-based analytical techniques for simultaneous determination of Naltrexone hydrochloride (NTX) and Bupropion hydrochloride (BUP): a comprehensive review. Discover Applied Sciences 6:5.
Crossref
Tomas Kukucka, Nikola Ferencova, Zuzana Visnovcova, Igor Ondrejka, Igor Hrtanek, Veronika Kovacova, Andrea Macejova, Zuzana Mlyncekova & Ingrid Tonhajzerova. (2024) Mechanisms Involved in the Link between Depression, Antidepressant Treatment, and Associated Weight Change. International Journal of Molecular Sciences 25:8, pages 4511.
Crossref
Julia SpadiMaike Scherf-ClavelAnna Linda LeutritzBarbara HützMaria MatentzogluMatthias NieberlerMax KurlbaumStefanie HahnerCatharina Bartmann, Rhiannon V. McNeillSarah Kittel-Schneider. (2024) Changes in Psychotropic Drug Concentrations Across the Menstrual Cycle: A Pilot Study. Therapeutic Drug Monitoring 46:2, pages 195-202.
Crossref
Brittany Finocchio & Wanda Hilliard. (2024) Therapeutic Outcomes of Treatment With Long-Acting Injectable Antipsychotics in Forensic Populations With Schizophrenia-Spectrum Diagnoses. Journal of Correctional Health Care 30:2, pages 71-81.
Crossref
Hoa Quynh Do, Elham Pirayesh, Garren Ferreira, Akash Pandhare, Zackary Ryan Gallardo & Michaela Jansen. (2024) A bupropion modulatory site in the Gloeobacter violaceus ligand-gated ion channel. Biophysical Journal.
Crossref
Paul M. Cinciripini, David W. Wetter, Jian Wang, Robert Yu, George Kypriotakis, Tapsi Kumar, Jason D. Robinson, Yong Cui, Charles E. Green, Andrew W. Bergen, Thomas R. Kosten, Steven E. Scherer & Sanjay Shete. (2024) Deep sequencing of candidate genes identified 14 variants associated with smoking abstinence in an ethnically diverse sample. Scientific Reports 14:1.
Crossref
Roongroj Bhidayasiri, Onanong Phokaewvarangkul, Hui-Fang Shang, Thien Thien Lim, Jin Whan Cho, Pramod Kumar Pal & Hirohisa Watanabe. (2024) Tardive dyskinesia in Asia— current clinical practice and the role of neurologists in the care pathway. Frontiers in Neurology 15.
Crossref
Peter Kenneth Gillman, Vincent Van den Eynde & Charles Redhead. (2023) A five‐pronged critique of ‘Serotonin syndrome—A focused review’. Basic & Clinical Pharmacology & Toxicology 133:5, pages 548-549.
Crossref
Shuzhe Zhou, Pei Li, Xiaozhen Lv, Xuefeng Lai, Zuoxiang Liu, Junwen Zhou, Fengqi Liu, Yiming Tao, Meng Zhang, Xin Yu, Jingwei Tian & Feng Sun. (2023) Adverse effects of 21 antidepressants on sleep during acute-phase treatment in major depressive disorder: a systemic review and dose-effect network meta-analysis. SLEEP 46:10.
Crossref
Giuliana Perrotte, Marina Maria Gonzaga Moreira, Amauri de Vargas Junior, Alvaro Teixeira Filho & João Mauricio Castaldelli-Maia. (2023) Effects of Caffeine on Main Symptoms in Children with ADHD: A Systematic Review and Meta-Analysis of Randomized Trials. Brain Sciences 13:9, pages 1304.
Crossref
Trent D. Emerick, Thomas J. MartinDouglas G. Ririe. (2023) Perioperative Considerations for Patients Exposed to Psychostimulants. Anesthesia & Analgesia 137:3, pages 474-487.
Crossref
Eleni Evgenidou, Androniki Rapti, Lelouda-Athanasia Koronaiou, Styliani Petromelidou, Kyriaki Anagnostopoulou & Dimitra Lambropoulou. (2023) Photocatalytic degradation of the antidepressant drug bupropion. Performance, water matrix effect and identification of transformation products. Sustainable Chemistry for the Environment 3, pages 100028.
Crossref
Austin Clark, Brendan Tate, Bretton Urban, Ryan Schroeder, Sonja Gennuso, Shahab Ahmadzadeh, David McGregor, Brook Girma, Sahar Shekoohi & Alan D. Kaye. (2023) Bupropion Mediated Effects on Depression, Attention Deficit Hyperactivity Disorder, and Smoking Cessation. Health Psychology Research 11.
Crossref
Karolina Słoczyńska, Justyna Orzeł, Aleksandra Murzyn, Justyna Popiół, Agnieszka Gunia-Krzyżak, Paulina Koczurkiewicz-Adamczyk & Elżbieta Pękala. (2023) Antidepressant pharmaceuticals in aquatic systems, individual-level ecotoxicological effects: growth, survival and behavior. Aquatic Toxicology 260, pages 106554.
Crossref
Min Yue, Lauren Kus, Shilpa Katta, Isaac Su, Lang Li, David M. Haas & Sara K. Quinney. (2023) Pharmacokinetics of Antidepressants in Pregnancy. The Journal of Clinical Pharmacology 63:S1.
Crossref
Ricardo Jorge Dinis-Oliveira. (2023) No Boundaries for Toxicology in Clinical Medicine: One Health, One Society and One Planet for All of Us. Journal of Clinical Medicine 12:8, pages 2808.
Crossref
Rita P. Lopes, Raquel A. Ferro, Margarida Milhazes, Margarida Figueira, Maria João Caldeira, Alexandra M. M. Antunes & Helena Gaspar. (2023) Metabolic stability and metabolite profiling of emerging synthetic cathinones. Frontiers in Pharmacology 14.
Crossref
Blake R. EricksonJarrod EhrieSamuel MurrayRyan J. DoughertyMilton L. WainbergLisa B. DixonMatthew L. Goldman. (2023) A Rapid Review of “Low-Threshold” Psychiatric Medication Prescribing: Considerations for Street Medicine and Beyond. Psychiatric Services 74:3, pages 282-291.
Crossref
Tiziana Mundula, Simone Baldi, Elisabetta Gerace & Amedeo Amedei. (2023) Role of the Intestinal Microbiota in the Genesis of Major Depression and the Response to Antidepressant Drug Therapy: A Narrative Review. Biomedicines 11:2, pages 550.
Crossref
Nadia O Bamfo, Jessica BL Lu & Zeruesenay Desta. (2023) Stereoselective Metabolism of Bupropion to Active Metabolites in Cellular Fractions of Human Liver and Intestine. Drug Metabolism and Disposition 51:1, pages 54-66.
Crossref
Juan Esteban Correa-Morales, Laura Cuellar-Valencia, Nidia Mantilla-Manosalva, Elias Quintero-Muñoz, María Fernanda Iriarte-Aristizábal, Sara Giraldo-Moreno & Luisa Fernanda Rodríguez-Campos. (2023) Cancer and Non-cancer Fatigue Treated With Bupropion: A Systematic Review. Journal of Pain and Symptom Management 65:1, pages e21-e28.
Crossref
David Love & Nicole S. Jones. (2023) Interpol Review of Drug Analysis 2019-2022. Forensic Science International: Synergy 6, pages 100299.
Crossref
Justin R. Yates. 2023. Determinants of Addiction. Determinants of Addiction 45 90 .
Jenny Berezanskaya, William Cade, Thomas M. Best, Kristopher Paultre & Carolyn Kienstra. (2022) ADHD Prescription Medications and Their Effect on Athletic Performance: A Systematic Review and Meta-analysis. Sports Medicine - Open 8:1.
Crossref
Matteo Vismara, Beatrice Benatti, Gregorio Nicolini, Ilaria Cova, Edoardo Monfrini, Alessio Di Fonzo, Vincenza Fetoni, Caterina A. Viganò, Alberto Priori & Bernardo Dell’Osso. (2022) Clinical uses of Bupropion in patients with Parkinson’s disease and comorbid depressive or neuropsychiatric symptoms: a scoping review. BMC Neurology 22:1.
Crossref
Michael J. Colwell, Hosana Tagomori, Sarah Chapman, Amy L. Gillespie, Philip J. Cowen, Catherine J. Harmer & Susannah E. Murphy. (2022) Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research. Translational Psychiatry 12:1.
Crossref
Aravind Shyamprasad Rekharani, Bala Sai Soujith NidamanuriPraharsh Kumar Mandadhi RajendraSenthil VenkatachalamJubie SelvarajJawahar Natarajan. (2022) Formulation, Optimization and Characterization of Bupropion Hydrochloride Loaded Nanostructured Lipid Carriers for Intra-Nasal Administration: An Approach to Management of Smoking Cessation. Current Nanomedicine 12:3, pages 217-232.
Crossref
Oleksandr Kozlov, Daniela Záhoráková, Daniel W. Armstrong & Taťána Gondová. (2022) Enantiomeric separation of bupropion by liquid chromatography on derivatized cyclofructan chiral stationary phase. Chirality 34:10, pages 1311-1319.
Crossref
Brandon T. Gufford, Ingrid F. Metzger, Nadia O. Bamfo, Eric A. Benson, Andrea R. Masters, Jessica Bo Li Lu & Zeruesenay Desta. (2022) Influence of CYP2B6 Pharmacogenetics on Stereoselective Inhibition and Induction of Bupropion Metabolism by Efavirenz in Healthy Volunteers . Journal of Pharmacology and Experimental Therapeutics 382:3, pages 313-326.
Crossref
Johanna J. Nugteren-van Lonkhuyzen, Sharon Essink, Saskia J. Rietjens, Dana Ohana, Dylan W. de Lange, Antoinette J.H.P. van Riel & Laura Hondebrink. (2022) 3-Methylmethcathinone (3-MMC) Poisonings: Acute Clinical Toxicity and Time Trend Between 2013 and 2021 in the Netherlands. Annals of Emergency Medicine 80:3, pages 203-212.
Crossref
Daniel J. McCabe, Joshua B. Radke & Bryan Z. Wilson. (2022) Disposition, outcomes, and lengths of stay due to bupropion overdose at a tertiary care center with a medical toxicology service. The American Journal of Emergency Medicine 54, pages 269-273.
Crossref
Hadrien Willame, Benjamin Wacquier, Camille Point, Marjorie Dosogne, Mohammed Al Faker, Gwenolé Loas & Matthieu Hein. (2022) The association between type 2 diabetes and anhedonic subtype of major depression in hypertensive individuals. The Journal of Clinical Hypertension 24:2, pages 156-166.
Crossref
Daniel J. McCabe, Eric McGillis & Benjamin A. Willenbring. (2022) The Timing of Clinical Effects of Bupropion Misuse Via Insufflation Reported to a Regional Poison Center. The Journal of Emergency Medicine 62:2, pages 175-181.
Crossref
Simone Sartori, Valentina Brilli, Cecilia Lanzi, Luca Pratticò, Elisabetta Sarcoli, Maria Grazia Di Milia, Francesco Gambassi & Guido Mannaioni. (2021) Acute intoxication following massive bupropion sniffing: A case report. Emergency Care Journal 17:4.
Crossref
Faruk Kurhan, Gülsüm Zuhal Kamış & Emine füsun Akyüz Çim. (2021) Acute dystonia following epileptic seizure after bupropion intoxication. Neurological Sciences 42:10, pages 4381-4386.
Crossref
Sujin Bae, Sunhye Park & Doug Hyun Han. (2021) A mixed herbal extract as an adjunctive therapy for attention deficit hyperactivity disorder: A randomized placebo-controlled trial. Integrative Medicine Research 10:3, pages 100714.
Crossref
Daniel J. McCabe, Eric McGillis & Benjamin A. Willenbring. (2021) Clinical effects of intravenous bupropion misuse reported to a regional poison center. The American Journal of Emergency Medicine 47, pages 86-89.
Crossref
Jorge Soares, Vera Marisa Costa, Maria de Lourdes Bastos, Félix Carvalho & João Paulo Capela. (2021) An updated review on synthetic cathinones. Archives of Toxicology 95:9, pages 2895-2940.
Crossref
Sakina J. Rizvi, Wiebke Gandhi & Tim Salomons. (2021) Reward processing as a common diathesis for chronic pain and depression. Neuroscience & Biobehavioral Reviews 127, pages 749-760.
Crossref
Julian Maier, Laurin Rauter, Deborah Rudin, Marco Niello, Marion Holy, Diethart Schmid, Joseph Wilson, Bruce E. Blough, Brenda M. Gannon, Kevin S. Murnane & Harald H. Sitte. (2021) α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter. Neuropharmacology 190, pages 108570.
Crossref
Fatima Zahra Marok, Laura Maria Fuhr, Nina Hanke, Dominik Selzer & Thorsten Lehr. (2021) Physiologically Based Pharmacokinetic Modeling of Bupropion and Its Metabolites in a CYP2B6 Drug-Drug-Gene Interaction Network. Pharmaceutics 13:3, pages 331.
Crossref
Yingtan Wang, Zhe Lu & Guanglei Xun. (2021) Pathological gambling in a patient on piribedil. Medicine 100:6, pages e24568.
Crossref
Beatriz T. Lopes, Maria João Caldeira, Helena Gaspar & Alexandra M. M. Antunes. (2021) Metabolic Profile of Four Selected Cathinones in Microsome Incubations: Identification of Phase I and II Metabolites by Liquid Chromatography High Resolution Mass Spectrometry. Frontiers in Chemistry 8.
Crossref
Francisco Basílio & Ricardo Jorge Dinis-Oliveira. (2021) Clinical and Forensic Aspects of Pharmacobezoars. Current Drug Research Reviews 12:2, pages 118-130.
Crossref
Joseph SadekJoseph Sadek. 2021. Clinician’s Guide to Psychopharmacology. Clinician’s Guide to Psychopharmacology 17 57 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.